BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 8750636)

  • 1. Is P-glycoprotein a sufficient marker for multidrug resistance in vivo? Immunohistochemical staining for P-glycoprotein in children and adult leukemia: correlation with clinical outcome.
    Kaczorowski S; Ochocka M; Kaczorowska M; Aleksandrowicz R; Matysiakl M; Karwacki M
    Leuk Lymphoma; 1995 Dec; 20(1-2):143-52. PubMed ID: 8750636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New flow cytometric method for detection of minimally expressed multidrug resistance P-glycoprotein on normal and acute leukemia cells using biotinylated MRK16 and streptavidin-RED670 conjugate.
    Takeshita A; Shinjo K; Ohnishi K; Ohno R
    Jpn J Cancer Res; 1995 Jun; 86(6):607-15. PubMed ID: 7622426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of immunohistochemical detection of P-glycoprotein in chronic lymphoid disorders.
    Attal M; Bibeau F; Muller C; Duchayne E; Kuhlein E; Cassar G; Delsol G; Laurent G
    Am J Clin Pathol; 1994 Dec; 102(6):842-9. PubMed ID: 7801902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
    Pituch-Noworolska A
    Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical importance of P-glycoprotein-related resistance in leukemia and myelodysplastic syndromes--first experience with their reversal.
    Nüssler V; Pelka-Fleischer R; Zwierzina H; Nerl C; Beckert B; Gullis E; Gieseler F; Bock S; Bartl R; Petrides PE
    Ann Hematol; 1994; 69 Suppl 1():S25-9. PubMed ID: 7914749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discordance of P-glycoprotein expression and function in acute leukemia.
    De Moerloose B; Dhooge C; Philippé J
    Adv Exp Med Biol; 1999; 457():107-18. PubMed ID: 10500786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P-glycoprotein expression in acute myeloblastic leukemia analyzed by immunocytochemistry and flow cytometry.
    Longo R; Bensi L; Vecchi A; Messora C; Sacchi S
    Leuk Lymphoma; 1995 Mar; 17(1-2):121-5. PubMed ID: 7773148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal immunocytochemical and flow cytometric detection of P-gp, MRP and LRP in childhood acute lymphoblastic leukemia.
    Den Boer ML; Zwaan CM; Pieters R; Kazemier KM; Rottier MM; Flens MJ; Scheper RJ; Veerman AJ
    Leukemia; 1997 Jul; 11(7):1078-85. PubMed ID: 9204995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absolute levels of MDR-1, MRP, and BCL-2 MRNA and tumor remission in acute leukemia.
    Köhler T; Leiblein S; Borchert S; Eller J; Rost AK; Lassner D; Krahl R; Helbig W; Wagner O; Remke H
    Adv Exp Med Biol; 1999; 457():177-85. PubMed ID: 10500792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of P-glycoprotein expression and function for response to induction chemotherapy, relapse rate and overall survival in acute leukemia.
    Wuchter C; Leonid K; Ruppert V; Schrappe M; Büchner T; Schoch C; Haferlach T; Harbott J; Ratei R; Dörken B; Ludwig WD
    Haematologica; 2000 Jul; 85(7):711-21. PubMed ID: 10897123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of multidrug resistance evaluated by means of the quantitative immunohistochemical detection of P-glycoprotein and the functional release of rhodamine 123.
    Delville JP; Pradier O; Pauwels O; Van Onderbergen A; Kiss R; Feremans W; Capel P
    Am J Hematol; 1995 Jul; 49(3):183-93. PubMed ID: 7604811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of P-glycoprotein (P-gp) expression in childhood acute lymphoblastic leukemia. Results of a 6-year prospective study.
    Dhooge C; De Moerloose B
    Adv Exp Med Biol; 1999; 457():11-9. PubMed ID: 10500775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P-gp expression and Rh 123 efflux assay have no impact on survival in Egyptian pediatric acute lymphoblastic leukemia patients.
    Kamel AM; El-Sharkawy N; Yassin D; Shaaban K; Hussein H; Sidhom I; Abo El-Naga S; Ameen M; El-Hattab O; Aly El-Din NH
    J Egypt Natl Canc Inst; 2005 Sep; 17(3):165-72. PubMed ID: 16799654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of multidrug resistant phenotype by flow cytometry with monoclonal antibodies and functional tests.
    Lizard G; Maynadié M; Roignot P; Lizard-Nacol S; Poupon MF
    Bull Cancer; 1995 Mar; 82(3):211-7. PubMed ID: 7655150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunocytochemical detection of the multidrug resistance-associated protein and P-glycoprotein in acute myeloid leukemia: impact of antibodies, sample source and disease status.
    Filipits M; Suchomel RW; Lechner K; Pirker R
    Leukemia; 1997 Jul; 11(7):1073-7. PubMed ID: 9204994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the multidrug resistance-associated P-glycoprotein (P-170) in 59 cases of de novo acute lymphoblastic leukemia: prognostic implications.
    Goasguen JE; Dossot JM; Fardel O; Le Mee F; Le Gall E; Leblay R; LePrise PY; Chaperon J; Fauchet R
    Blood; 1993 May; 81(9):2394-8. PubMed ID: 8097634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical relevance of P-glycoprotein expression in de novo acute myeloid leukemia.
    Del Poeta G; Stasi R; Aronica G; Venditti A; Cox MC; Bruno A; Buccisano F; Masi M; Tribalto M; Amadori S; Papa G
    Blood; 1996 Mar; 87(5):1997-2004. PubMed ID: 8634450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the multidrug transporter, P-glycoprotein, in acute leukemia cells and correlation to clinical drug resistance.
    Kuwazuru Y; Yoshimura A; Hanada S; Utsunomiya A; Makino T; Ishibashi K; Kodama M; Iwahashi M; Arima T; Akiyama S
    Cancer; 1990 Sep; 66(5):868-73. PubMed ID: 1974821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of two functional flow cytometric assays to assess P-gp activity in acute leukemia.
    Swerts K; de Moerloose B; Dhooge C; Noens L; Laureys G; Benoit Y; Philippé J
    Leuk Lymphoma; 2004 Nov; 45(11):2221-8. PubMed ID: 15512810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the multidrug transporter P-glycoprotein is highly correlated with clinical outcome in childhood acute lymphoblastic leukemia: results of a long-term prospective study.
    Dhooge C; De Moerloose B; Laureys G; Ferster A; De Bacquer D; Philippe J; Leroy J; Benoit Y
    Leuk Lymphoma; 2002 Feb; 43(2):309-14. PubMed ID: 11999562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.